Apr. 28 at 3:38 PM
$ACUT Feeling very excited for Accustem, here’s why: 📈🚀
The LDCT scan is the existing market leader for the lung cancer diagnostics market. In terms of accuracy, it has it’s deficiencies and there is a genuine gap in the market for a better test.
The MSC test from Accustem is a blood test that works alongside the market leader to increase accuracy.
Being a blood test, it will be relatively cost effective and an absolute no brainer for physicians and medical insurance providers, improving the chances for patients.